Follow The Filings

NEOV Neovolta Inc.

Filed as NEOVOLTA INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 exit

In 2026 Q2 Davidson Kempner Capital Management sold out of Neovolta.

Who owns NEOV

Sorted by value, long equity only, as of 2026 Q2.

History
Davidson Kempner Capital Management exited 2026 Q2 Last 2026 Q1 0.02% Exit −0.02% 400,000 $1.2M History

0 current, 1 exited last period, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by NEOV's executives, directors and 10% owners in the last 12 months, from their Form 4s

All NEOV insider trades
  • $297K bought by 2 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. John A Hass Director
    Buy
    $65K 25,000 shares at $2.61 +25% to stake
    Traded Sep 30 Filed Oct 15
    ↗
  2. John A Hass Director
    Buy
    $48K 25,000 shares at $1.92 +33% to stake
    Traded Jun 11 Filed Jun 12
    ↗
  3. Steve Bond Executive Vice President
    Buy
    $86K 43,000 shares at $1.99 +5.4% to stake
    Traded Jun 1 Filed Jun 2
    ↗
  4. Steve Bond Executive Vice President
    Buy
    $98K 47,000 shares at $2.09 +6.3% to stake
    Traded May 19 Filed May 20
    ↗
  5. Brent Willson 10% owner
    Sale
    $5,000 500,000 shares at $0.0100 12% of stake
    Traded Oct 8, 2025 Filed Oct 10, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 2 option exercises.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
424B3 FORM 424(B)(3) Filing Doc
424B3 FORM 424B3 Filing Doc
10-K FORM 10-K FOR JUN 2026 Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.01,2.03,3.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 1.01,8.01,9.01 Filing Doc
424B5 PROSPECTUS SUPPLEMENT TO PROSPECTUS DATED 6-28-24 Filing Doc
424B5 FORM 424B5 Filing Doc
10-Q FORM 10-Q FOR MAR 2026 Filing Doc
8-K 2.02,5.02,9.01 Filing Doc
8-K 1.01,3.02,9.01 Filing Doc
424B5 424B5 PROSPECTUS SUPPLEMENT Filing Doc
8-K 1.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.02,9.01 Filing Doc
10-Q FORM 10-Q FOR DEC 2025 Filing Doc
8-K/A 5.02 Filing Doc
8-K 5.02 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 1.01,2.02,7.01,9.01 Filing Doc
424B5 PROSPECTUS Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 3.02 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025 FY2026
Revenue $3.46M $2.65M $8.43M $13.33M
Gross profit $0.688M $0.51M $1.51M $2.14M
Gross margin * 19.9% 19.3% 17.9% 16.0%
Net income -$2.64M -$2.3M -$5.03M -$21.47M
Net margin * -76.4% -87.1% -59.7% -161.0%

Balance sheet

Metric FY2023 FY2024 FY2025 FY2026
Total current assets $6.51M $4.66M $6.66M $32.85M
Total non-current assets * $0M $0M $0.141M $20.79M
Total assets $6.51M $4.66M $6.81M $53.64M
Total current liabilities $0.039M $0.061M $3.51M $6.68M
Total non-current liabilities * $0M — $0.384M $7.39M
Total equity $6.47M $4.6M $2.91M $39.57M

Cash flow

Metric FY2023 FY2024 FY2025 FY2026
Cash from operations -$2.11M -$1.02M -$4.43M -$15.19M
Cash from investing — — — -$8.63M
Cash from financing $3.78M $0M $4.23M $48.38M
Net change in cash * — — — $24.56M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Q1 2026

Period archive